Search Results - Irina V. Vakhlova

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Evaluation of the Effectiveness of Using the CFTR Modulator Ivacaftor/Lumacaftor in Children with Cystic Fibrosis in the Sverdlovsk Region (Prospective Cohort Study) by Yuliya O. Vasenyova, Irina V. Vakhlova, Oleg Yu. Averyanov

    Published 2024-09-01

    Background. A modern achievement in the treatment of cystic fibrosis has been the discovery of small molecules that restore the processes of synthesis, transport to the membrane, and the work of the defective CFTR protein. Drugs whose action is aimed at restoring the function of the CFTR protein are...

    Full description

    Get full text
    Article
  2. 2

    Association of Gene Variants of Plasmic (<i>FGB</i> -455 G>A (rs1800790), <i>F2</i> 20210 G>A (rs1799963), <i>F5</i> 1691 G>A (rs6025), <i>F7</i> 10976 G>A (rs6046), <i>F13</i> G>T... by Olesia A. Filippova, Irina V. Vakhlova, Nikolay N. Kuznetsov, Tatiana B. Abolina, Grigory A. Tsaur

    Published 2020-11-01

    Background. The severity of thrombosis clinical course, poor prognosis, upcoming disability and permanent organ failure in newborns necessitate further search and study of thrombotic conditions predictors in order to prevent them. Aim of the study is to analyze the frequency of gene variants of plas...

    Full description

    Get full text
    Article
  3. 3

    Modern Approaches to the Management of Children with Mucopolysaccharidosis Type I by Galina V. Baidakova, Alexander A. Baranov, Irina V. Vakhlova, Nato D. Vashakmadze, Elena Yu. Voskoboeva, Ekaterina Yu. Zakharova, Ludmila M. Kuzenkova, Sergey I. Kutsev, Valentina I. Larionova, Tina V. Lobzhanidze, Ludmila K. Mikhailova, Svetlana V. Mikhailova, Sergey V. Moiseev, Leyla S. Namazova-Baranova, Sergey S. Nikitin, Natalya L. Pechatnikova, Olga A. Polyakova, Alla N. Semyachkina, Olga V. Udalova

    Published 2022-10-01

    This article presents modern data on epidemiology, etiology, and clinical manifestations of mucopolysaccharidosis (MPS) type I in children. MPS develops due to deficiency of particular lysosomal enzyme which determines the disease type. The article considers in details disease's pathogenesis an...

    Full description

    Get full text
    Article
  4. 4
  5. 5